CraniYums: An Effective New Tool for Dieters?

For women, improvement of symptoms -- including craving for carbohydrates, especially in the afternoon and evening -- usually requires a full two weeks of consistent use – 1-2 lozenges three to four times daily. Many women note marked improvement in the first week while for others, 2 to 4 weeks may be required. Women usually choose to supplement Essential Balance with PM Craving Control after their initial two weeks of use. In general, women require higher total amounts than men for relief of symptoms.

Usually, after one week of ingestion by men and two weeks ingestion by women, the initial amounts of Essential Balance may be reduced and then supplemented with either Energy Boost and/or PM Craving Control depending on whether they need more dopamine effects or serotonin effects.

The basis for the differences in responses to CraniYums in men and women may be the result of women’s relatively lower serotonin levels, compared to men. It may also reflect the significant reduction in serotonin levels of women who are dieting.

Once neurotransmitter deficiencies have been corrected with the one to two week consistent use of CraniYums, patients find that they can use the products on an as-needed basis and experience relief of symptoms within ½ hour of dosing. Symptom relief usually lasts three to four hours between doses.

The product is available at the Craniyums web site.

Results of a Study by Dr. Hart

In a double-blind study involving sixteen (16) women participants conducted by Dr. Hart, two (2) CraniYums were given three times a day to half the participants and placebo was given to the other participants. The study lasted for six (6) weeks and participants were asked to fill out a symptoms rating response once a week. The 23 symptoms of neurotransmitter deficiencies (listed earlier in this article) were listed on the symptoms rating sheet.

CraniYums use resulted in a decrease in the severity of twenty two (22) of the twenty three (23) symptoms of neurotransmitter deficiencies. The decrease of three (3) of the symptoms was not significantly greater than in the placebo group.

In the nineteen (19) symptoms that showed significant improvement, the average improvement with CraniYums use was 59% (range 30% to 81%) and in the placebo group was 18% (range 0 to 34%) for the same symptoms. Greatest improvements were noted with these symptoms:

• Depressed mood
• Fatigue
• Anxiety or worry
• Achy muscles
• Sleep problems
• Not feeling satisfied after eating (eating satiation)
• Anger

Significant improvements were also noted with the symptoms:

• Fearfulness
• PMS moodiness
• Muscle strength
• Thing a lot about food
• Irritability
• Focus
• Craving starchy carbohydrates
• Craving in p.m.
• Motivation
• Food portions
• Chocolate cravings

Dr. Hart concluded that her studies demonstrated that the use of CraniYums as directed over a six (6) week period affected the symptoms of neurotransmitter deficiencies in the following ways:

• Improves eating satisfaction
• Improves mood
• Lowers anger and irritability
• Lessens fatigue
• Lowers anxiety and fearfulness
• Relieves achy muscles
• Improves sleep
• Lessens appetite and cravings especially for starchy or sweet carbohydrates
• Improves motivation, mental focus and muscle strength
• Improves PMS-related moodiness

Side Effects

While there are no serious side effects noted with the use of recommended doses of CraniYums, some patients do experience headache and/or nausea when first using this preparation. These side effects are noted more often in patients who have significant neurotransmitter deficiencies or who are taking selective serotonin reuptake inhibitors (SSRIs). Dr. Hart recommends reducing the intake of CraniYums to see if lower amounts are tolerated. These side effects tend to disappear with reduced dose and continued use.

CraniYums and Hypothyroid Patients

When Dr. Hart sees patients who are stressed and show signs of adrenal insufficiency, they may appear to be hypothyroid. She generally measures TSH, free T3 and T4, and reverse T3 in some patients. She has found that patients of this type who do not respond as expected to CraniYums often do respond if they receive appropriate thyroid hormone replacement therapy.

>> What is Mary Shomon's experience with CraniYums? Read Part 3... now